These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
666 related articles for article (PubMed ID: 22335920)
21. Heparanase: From basic research to therapeutic applications in cancer and inflammation. Vlodavsky I; Singh P; Boyango I; Gutter-Kapon L; Elkin M; Sanderson RD; Ilan N Drug Resist Updat; 2016 Nov; 29():54-75. PubMed ID: 27912844 [TBL] [Abstract][Full Text] [Related]
22. Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance. Wilting RH; Dannenberg JH Drug Resist Updat; 2012; 15(1-2):21-38. PubMed ID: 22356866 [TBL] [Abstract][Full Text] [Related]
31. The role of exosomes and miRNAs in drug-resistance of cancer cells. Bach DH; Hong JY; Park HJ; Lee SK Int J Cancer; 2017 Jul; 141(2):220-230. PubMed ID: 28240776 [TBL] [Abstract][Full Text] [Related]
39. miRNA Deregulation in Cancer Cells and the Tumor Microenvironment. Rupaimoole R; Calin GA; Lopez-Berestein G; Sood AK Cancer Discov; 2016 Mar; 6(3):235-46. PubMed ID: 26865249 [TBL] [Abstract][Full Text] [Related]
40. How changes in extracellular matrix mechanics and gene expression variability might combine to drive cancer progression. Werfel J; Krause S; Bischof AG; Mannix RJ; Tobin H; Bar-Yam Y; Bellin RM; Ingber DE PLoS One; 2013; 8(10):e76122. PubMed ID: 24098430 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]